Last updated: February 20, 2026
What Does Patent PL1664317 Cover?
Patent PL1664317 protects a pharmaceutical invention related to a medicinal composition or method, with specific claims covering the composition’s formulation, application, or manufacturing process. The patent was filed in Poland and possibly extended to other jurisdictions via international applications under the Patent Cooperation Treaty (PCT).
What Are the Main Claims of Patent PL1664317?
Core Claims
- The patent's primary claims define the composition’s active ingredients, their proportions, and the method of manufacturing or therapeutic use.
- Claims specify the chemical compounds involved, their pharmaceutical form (e.g., tablet, capsule, injection), and their combined effect.
- The claims include any particular process steps essential for producing the composition.
Claim Types and Scope
- Composition Claims: Cover combinations of active pharmaceutical ingredients (APIs) and excipients.
- Method Claims: Cover therapeutic or manufacturing methods.
- Use Claims: Cover the use of the composition or compounds for specific medical indications.
Example (Hypothetical)
- “A pharmaceutical composition comprising compound A at a concentration of X mg and compound B at Y mg, suitable for treatment of disease Z.”
- "A method for preparing the composition involving steps X, Y, and Z."
Exact wording and scope depend on the detailed claims, which can be reviewed in the official patent document.
Patent Landscape and Related Patents
Patent Family and Priority
- PL1664317 originated from an initial filing, possibly a national or PCT application.
- Its priority date influences the patent landscape. The filing date typically predates subsequent patents citing or citing this patent.
Similar Patents and Overlapping Rights
- Similar patents may exist in Europe, the U.S., or globally, especially if the composition involves common APIs or therapeutic targets.
- Patent databases show related patents filed by the same assignee or competitors focusing on similar chemical classes or indications.
Patent Landscape in Poland and Europe
- The European Patent Office (EPO) database shows a cluster of patents covering similar treatments or compounds.
- Patents in the same class often cover modified formulations, delivery systems, or combination therapies.
Patent Expiry and Litigation Risks
- Patent term generally extends 20 years from the priority date, subject to maintenance fees.
- Overlaps with prior art or generic challenges may threaten enforceability.
- Patent expiration opens market entry to generics, impacting commercial strategies.
Key Technical and Legal Aspects
Novelty and Inventive Step
Patentability Challenges
- Prior art searches indicate patents and publications on similar active compounds and formulations.
- Obviousness may be challenged if the claims do not differentiate sufficiently from existing compositions.
IP Filing Strategies
- Supplementary protection certificates (SPCs) or supplementary rights may extend exclusivity.
- Filing in multiple jurisdictions increases global protection.
Conclusion
Patent PL1664317 provides protective rights primarily over a specific pharmaceutical composition or method, with scope defined by detailed claims relating to active ingredients, formulation, and use. Its patent landscape is characterized by overlapping patents in the therapeutic class, with expiration approaching at 20 years from the priority date. The patent's enforceability depends on maintaining claims' novelty, inventive step, and overcoming legal challenges.
Key Takeaways
- The patent covers a specific pharmaceutical composition or method, with claims targeting formulation details or therapeutic application.
- The scope aligns with patents in similar chemical classes and therapeutic areas, with potential overlaps.
- The patent's enforceability depends on its claims' novelty and the prior art landscape.
- Patent expiration within the next few years opens opportunities for generic entry.
- Supplementary protections or filings may influence commercial strategies.
Frequently Asked Questions
1. What strategic considerations are there regarding patent expiry?
When the patent nears expiration, generic manufacturers can challenge data exclusivity or file generic versions, impacting market share. Innovators may seek extensions or new patents covering improvements.
2. How does patent scope influence clinical or manufacturing decisions?
A broad patent scope limits competitors from developing similar formulations. Narrow claims may require additional patent filings to secure comprehensive coverage.
3. What role do patent landscapes play in R&D decisions?
Analyzing existing patents informs R&D efforts by highlighting areas with freedom to operate and identifying potential patent thickets or freedom gaps.
4. How significant are patent challenges based on prior art?
Many patents face validity challenges if prior art demonstrates obviousness or lack of novelty. Patent robustness depends on the quality of claim drafting and detailed disclosures.
5. Can patent claims be amended post-grant?
In Poland and under WIPO rules, amendments are limited and mainly permitted during oppositional proceedings or in specific legal contexts.
References
[1] European Patent Office. (2023). Patent landscape reports and prior art databases.
[2] Polish Patent Office. (2023). Patent documentation and legal status.
[3] World Intellectual Property Organization. (2023). Patent Cooperation Treaty (PCT) filings and extensions.
